prostate tissue microarray (tma) Search Results


prostate cancer tissue microarrays (tma)  (BioChain Institute)
90
BioChain Institute prostate cancer tissue microarrays (tma)
Prostate Cancer Tissue Microarrays (Tma), supplied by BioChain Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prostate cancer tissue microarrays (tma)/product/BioChain Institute
Average 90 stars, based on 1 article reviews
prostate cancer tissue microarrays (tma) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
human prostate tissue microarray (tma)  (Johns Hopkins HealthCare)
90
Johns Hopkins HealthCare human prostate tissue microarray (tma)
AXL is not expressed in human prostate tumors. A, AXL expression prostate cancer patients who did and did not experience a biochemical recurrence (n = 1405 patients, GenomeDx GRID dataset). P value was calculated using the Wilcoxon rank test. B, Recurrence-free survival of patients with high (above the median) and low (below the median) AXL expression (n = 571 patients, Taylor et al, 2010 visualized and analyzed with Project Betastasis). C, Representative images of AXL IHC staining of a prostate tissue <t>microarray;</t> LN, lymph node. C42B cells served as a negative control, DU145 as a positive control. All images at original magnification x 200. D, AXL IHC staining in metastatic patient tissue; upper panel scale bar, 100 μm; lower panel scale bar, 50 μm.
Human Prostate Tissue Microarray (Tma), supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human prostate tissue microarray (tma)/product/Johns Hopkins HealthCare
Average 90 stars, based on 1 article reviews
human prostate tissue microarray (tma) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


AXL is not expressed in human prostate tumors. A, AXL expression prostate cancer patients who did and did not experience a biochemical recurrence (n = 1405 patients, GenomeDx GRID dataset). P value was calculated using the Wilcoxon rank test. B, Recurrence-free survival of patients with high (above the median) and low (below the median) AXL expression (n = 571 patients, Taylor et al, 2010 visualized and analyzed with Project Betastasis). C, Representative images of AXL IHC staining of a prostate tissue microarray; LN, lymph node. C42B cells served as a negative control, DU145 as a positive control. All images at original magnification x 200. D, AXL IHC staining in metastatic patient tissue; upper panel scale bar, 100 μm; lower panel scale bar, 50 μm.

Journal: Molecular cancer research : MCR

Article Title: AXL is a Putative Tumor Suppressor and Dormancy Regulator in Prostate Cancer

doi: 10.1158/1541-7786.MCR-18-0718

Figure Lengend Snippet: AXL is not expressed in human prostate tumors. A, AXL expression prostate cancer patients who did and did not experience a biochemical recurrence (n = 1405 patients, GenomeDx GRID dataset). P value was calculated using the Wilcoxon rank test. B, Recurrence-free survival of patients with high (above the median) and low (below the median) AXL expression (n = 571 patients, Taylor et al, 2010 visualized and analyzed with Project Betastasis). C, Representative images of AXL IHC staining of a prostate tissue microarray; LN, lymph node. C42B cells served as a negative control, DU145 as a positive control. All images at original magnification x 200. D, AXL IHC staining in metastatic patient tissue; upper panel scale bar, 100 μm; lower panel scale bar, 50 μm.

Article Snippet: Human prostate tissue microarray (TMA) staining This study was approved by the Johns Hopkins institutional internal review board and followed the U.S. Common Rule.

Techniques: Expressing, Immunohistochemistry, Microarray, Negative Control, Positive Control